Source comparison
MOTS-C Administration: Route Comparison
Intraperitoneal (IP) 10–15mg/kg 15–30 minutes 2–4 hours Rodent metabolic studies, whole-body glucose tolerance Fastest systemic distribution; ideal for acute intervention studies Subcutaneous (SC) 5–10mg/kg 60–90 minutes 4–6 hours Human trials, chronic dosing
This comparison does not assign a generated winner or score.
- Intraperitoneal (IP)
- 10–15mg/kg
- 15–30 minutes
- 2–4 hours
- Rodent metabolic studies, whole-body glucose tolerance
- Fastest systemic distribution; ideal for acute intervention studies
- Subcutaneous (SC)
- 5–10mg/kg
- 60–90 minutes
- 4–6 hours
- Human trials, chronic dosing protocols
- Slower release produces sustained AMPK activation; better for long-term studies
- Intravenous (IV)
- Immediate
- 1–2 hours
- Pharmacokinetic studies, dose-response trials
- Immediate peak but rapid clearance; impractical for sustained metabolic intervention